KR101395875B1 - Prebiotics Containing Extractions of Persimmon Leaves for Useful Strains in intestine - Google Patents

Prebiotics Containing Extractions of Persimmon Leaves for Useful Strains in intestine Download PDF

Info

Publication number
KR101395875B1
KR101395875B1 KR1020120128761A KR20120128761A KR101395875B1 KR 101395875 B1 KR101395875 B1 KR 101395875B1 KR 1020120128761 A KR1020120128761 A KR 1020120128761A KR 20120128761 A KR20120128761 A KR 20120128761A KR 101395875 B1 KR101395875 B1 KR 101395875B1
Authority
KR
South Korea
Prior art keywords
extract
prebiotics
bacteria
persimmon
persimmon leaf
Prior art date
Application number
KR1020120128761A
Other languages
Korean (ko)
Inventor
노정해
손동화
도정룡
이영경
신희순
김미현
엄지은
Original Assignee
한국식품연구원
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 한국식품연구원 filed Critical 한국식품연구원
Priority to KR1020120128761A priority Critical patent/KR101395875B1/en
Application granted granted Critical
Publication of KR101395875B1 publication Critical patent/KR101395875B1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36Adaptation or attenuation of cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/38Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to prebiotics containing extracts of persimmon leaves for promoting probiotic bacteria proliferation and suppressing growth of pathogenic bacteria. According to the present invention, as a water extract of the persimmon leaves is treated to promote the proliferation of probiotic bacteria and an ethanol extract of the persimmon leaves is treated to suppress growth of intestinal pathogenic bacteria, the prebiotics containing the extracts of persimmon leaves can control the growth of both probiotic bacteria and pathogenic bacteria. The extracts of persimmon leaves also can have an antioxidant effect by having a superior ability in electron donation.

Description

감잎 추출물을 포함하는 장내 유용균에 대한 프리바이오틱스{Prebiotics Containing Extractions of Persimmon Leaves for Useful Strains in intestine}{Prebiotics Containing Extracts of Persimmon Leaves for Useful Strains in intestine}

본 발명은 감잎 추출물을 포함하는 장내 유익균의 증식 촉진 및 장내 유해균의 생육 억제용 프리바이오틱스 및 이의 제조 방법에 관한 것이다.
The present invention relates to a prebiotics for promoting the proliferation of beneficial bacteria in the intestines including persimmon leaf extract and for inhibiting the growth of harmful bacteria in the intestines and a method for producing the same.

감나무(Diospyrus kaki)는 우리나라 중부 이남에서 잘 자라는 과실수 중 하나로 열매인 감은 독특한 맛을 가진 과실로서 이용되고, 감나무 잎은 감잎차의 원료로서 오래전부터 민간에서 이용되고 있다(Park et al., 1995). 감잎은 다양한 생리활성 물질을 함유하고 있는 것으로 알려져 있으며, 임상학적 약리 작용과 효능은 동의보감과 본초강목 등의 여러 고문헌에 잘 나타나 있다. 최근에는 감잎의 성분과 효과에 관한 연구가 최근 이루어져 있으며, 감잎에 대한 국내외의 연구로는 감잎의 성분, 감잎차의 제조 방법, 향기 성분, 조리 방법에 따른 비타민 C의 변화, 특별한 생리적 기능을 갖는 생리활성 물질에 관한 연구 등이 있다(Park et al., 1995, Woo et al., 2005, Moon & Park., 2000, An et al., 2003, Bae et al., 2000).Diospyrus kaki is one of the fruit trees that grow well in the middle of Korea. It is used as a fruit with a distinctive flavor, and persimmon leaves have long been used in the private sector as a source of persimmon leaves (Park et al., 1995) . Persimmon leaves are known to contain a variety of physiologically active substances, and their clinical pharmacokinetics and efficacy are well documented in various documents such as Dongbokbohang and Boncho Gangmok. Recently, studies on the components and effects of persimmon leaves have been made recently. Domestic and foreign researches on persimmon leaves have been carried out to investigate the composition of persimmon leaf, the preparation method of persimmon leaf tea, the composition of vitamins C according to the cooking method, (Park et al., 1995, Woo et al., 2005, Moon & Park, 2000, An et al., 2003, Bae et al., 2000).

인간의 장관 내에는 400여종 이상의 세균이 대장 내용물 g당 100조 정도의 숫자로 서식하고 있으며 일정한 균형을 유지하는 복잡한 생태계로 구성되어 있다. 장내 균총은 유익균과 유해균으로 나눌 수 있으며, 이들의 균형에 의해 건강상태가 조절된다. 건강을 유지하기 위해서는 유익균이 많고 유해균이 적은 상태로 장내 균총을 유지시켜야 한다. 균총은 외부에서 유입된 음식물이나 스트레스, 호르몬 분비 등 인체의 상태에 따라 변화될 수 있으며, 이들이 생성하는 효소와 대사산물들은 여러 가지 물질의 인체 내 대사에 관여하고, 영양분이나 약물의 흡수, 독성물질의 생성에 영향을 미친다. 따라서 식이 조절은 유익균의 장내 증식을 촉진시키고 유해균을 억제할 수 있는 방법 중 유용하며 천연물 소재 추출물을 이용하여 장내 유익균 증식에 관한 연구로는 인진쑥, 대추, 오미자 및 미나리 발효액 등이 있다.
More than 400 kinds of germs in the human intestine are composed of complicated ecosystems which are inhabited by the number of about 100 trillion per gram of contents of the bowel and maintaining a constant balance. Intestinal microflora can be divided into useful bacteria and harmful bacteria, and their health condition is controlled by their balance. In order to maintain health, it is necessary to maintain the intestinal microflora with a lot of beneficial bacteria and few harmful bacteria. Staphylococcus aureus can be changed according to the state of the body such as external food, stress, hormone secretion, etc., and the enzymes and metabolites that they produce are involved in the metabolism of various substances in the body, Lt; / RTI > Therefore, dietary control is useful for promoting intestinal proliferation of beneficial bacteria and inhibiting harmful bacteria. For the study on the proliferation of intestinal beneficial bacteria using extracts of natural materials, there are Enzymugus japonica, Jujube, Omija and Minari fermentation.

본 명세서 전체에 걸쳐 다수의 논문 및 특허문헌이 참조되고 그 인용이 표시되어 있다. 인용된 논문 및 특허문헌의 개시 내용은 그 전체로서 본 명세서에 참조로 삽입되어 본 발명이 속하는 기술 분야의 수준 및 본 발명의 내용이 보다 명확하게 설명된다.
Numerous papers and patent documents are referenced and cited throughout this specification. The disclosures of the cited papers and patent documents are incorporated herein by reference in their entirety to better understand the state of the art to which the present invention pertains and the content of the present invention.

본 발명자들은 천연물로부터 장 건강을 위한 프리바이오틱스를 개발하고자 예의 연구 노력하였다. 그 결과, 본 발명자들은 감잎 추출물이 장내 유익균의 증식을 촉진하고 장내 유해균의 생육을 억제하는 활성을 갖는 것을 확인함으로서, 본 발명을 완성하게 되었다.The present inventors have tried to develop prebiotics for intestinal health from natural products. As a result, the present inventors confirmed that the persimmon leaf extract has an activity of promoting the proliferation of beneficial bacteria in the intestines and inhibiting the growth of harmful bacteria in the intestines, thereby completing the present invention.

따라서 본 발명의 목적은 감잎 추출물을 포함하는 프리바이오틱스를 제공하는 데 있다.
Accordingly, an object of the present invention is to provide a prebiotics comprising a persimmon leaf extract.

본 발명의 다른 목적 및 이점은 하기의 발명의 상세한 설명, 청구범위 및 도면에 의해 보다 명확하게 된다.
Other objects and advantages of the present invention will become more apparent from the following detailed description of the invention, claims and drawings.

본 발명의 일 양태에 따르면, 본 발명은 감잎 추출물을 포함하는 장내 유익균의 증식 촉진 및 장내 유해균의 생육 억제용 프리바이오틱스를 제공한다.
According to one aspect of the present invention, there is provided a prebiotics for promoting the proliferation of beneficial bacteria in the intestines including persimmon leaf extract and for inhibiting the growth of harmful bacteria in the intestines.

본 발명자들은 천연물로부터 장 건강을 위한 프리바이오틱스를 개발하고자 예의 연구 노력하였다. 그 결과, 본 발명자들은 감잎 추출물이 장내 유익균의 증식을 촉진하고 장내 유해균의 생육을 억제하는 활성을 갖는 것을 확인하였다.The present inventors have tried to develop prebiotics for intestinal health from natural products. As a result, the present inventors confirmed that the persimmon leaf extract has an activity of promoting the proliferation of the beneficial bacteria in the intestines and inhibiting the growth of the intestinal pest.

따라서 본 발명은 감잎 추출물을 포함하는 프리바이오틱스에 관한 것이다.
Accordingly, the present invention relates to a prebiotics comprising persimmon leaf extract.

본 발명에서 사용되는 용어 "장내 유익균"은 "프로바이오틱스"와 동일한 의미로 섭취되어 장에 도달하였을 때 장내 환경에 유익한 작용을 하는 균주를 의미하며, 위산과 답즙산에서 살아남아 소장까지 도달하여 장에서 증식하고 정착하며, 장관 내에서 유용한 효과를 나타내고, 독성이 없으며 비변원성인 조건을 만족하는 균을 의미한다. 예컨대, 락토바실러스 속(Lactobacillus), 락토코커스 속(Lactococcus), 엔테로코커스 속(Enterococcus), 스트렙토코커스 속(Streptococcus) 및 비피도박테리움 속(Bifidobacterium)을 포함한다. 바람직하게는 상기 장내 유익균은 비피도박테리움 속, 락토바실러스 속 또는 스트렙토코커스 속 균주이고, 보다 바람직하게는 비피도박테리움 속 또는 스트렙토코커스 속 균주이다.As used herein, the term "Enterobacteriaceae in the intestines" refers to strains that have the same meaning as "probiotics" and have a beneficial effect on the intestinal environment when they reach the intestines. They survive in the stomach acid and the ascites juice and reach the small intestine, And which has a beneficial effect in the intestine, and which does not have toxicity, and which satisfies the non-mutagenic conditions. For example, includes the Lactobacillus genus (Lactobacillus), Lactococcus genus (Lactococcus), Enterococcus genus (Enterococcus), in Streptococcus (Streptococcus) and Bifidobacterium (Bifidobacterium). Preferably, the intestinal beneficial bacteria are Bifidobacterium, Lactobacillus or Streptococcus, more preferably Bifidobacterium or Streptococcus.

보다 바람직하게는 본 발명의 비피도박테리움 속 균주는 비피도박테리움 아돌레센티스(Bifidobacterium adolescentis)이고, 본 발명의 락토바실러스 속 균주는 락토바실러스 루테리(Lactobacillus reuteri)이며, 본 발명의 스트렙토코커스 속 균주는 스트렙토코커스 써모필러스(Streptococcus thermophilus)이다. 가장 바람직하게는 상기 비피도박테리움 속 균주는 비피도박테리움 아돌레센티스 KCTC 3352이고, 상기 락토바실러스 속 균주는 락토바실러스 루테리 KCTC 3594이며, 상기 스트렙토코커스 속 균주는 스트렙토코커스 서머필러스 KCTC 3658이다.More preferably, the Bifidobacterium adolescentis strain of the present invention is Bifidobacterium adolescentis , the Lactobacillus sp. Strain of the present invention is Lactobacillus reuteri , and the Streptococcus sp. strain is Streptococcus Thermo filler's (Streptococcus thermophilus ). Most preferably, the Bifidobacterium sp. Strain is Bifidobacterium adolescentis KCTC 3352, the Lactobacillus sp. Strain is Lactobacillus luteri KCTC 3594, and the Streptococcus sp. Strain is Streptococcus thermophilus KCTC 3658 .

본 발명에서 사용되는 용어 "장내 유해균"은 섭취되어 장에 도달하였을 때 장내 환경에 유해한 작용을 하는 균주를 의미한다. 예컨대, 슈도모나스 에루지노사 속(Pseudomonas - aeruginosa), 비브리오 속(Vibrio), 스태필로코커스 속(staphylococcus), 클로스트리디움 속(Clostridium perfringens), 유박테리움 속(Eubacterium), 박테로이드 속(Bacteroides) 균주 및 황환원균(sulfate reducers)을 포함한다. 바람직하게는 상기 장내 유해균은 클로스트리디움 속, 유박테리움 속 또는 박테로이드 속 균주이다.As used herein, the term "harmful bacteria in intestines " means a strain that is harmful to the intestinal environment when it is ingested and reaches the intestines. For example, in industrial Rouge Pseudomonas (Pseudomonas - aeruginosa), Vibrio genus (Vibrio), Staphylococcus genus (staphylococcus), Clostridium genus (Clostridium perfringens , Eubacterium , Bacteroides , and sulfate reducers . Preferably, the intestinal harmful bacteria are Clostridium genus, Ubertium genus or Bacteroid genus.

보다 바람직하게는 본 발명의 클로스트리디움 속 균주는 클로스트리디움 디피실리(Clostridium difficile) 또는 클로스트리디움 퍼프린젠스(Clostridium perfringens)이고, 본 발명의 유박테리움 속 균주는 유박테리움 리모숨(Eubacterium limosum)이며, 본 발명의 박테로이드 속 균주는 박테로이드 후라길리스(Bacteroides fragilis)이다. 가장 바람직하게는 상기 클로스트리디움 속 균주는 클로스트리디움 디피실리 KCTC 5009 또는 클로스트리디움 퍼프린젠스 KCTC 3269이고, 상기 유박테리움 속 균주는 유박테리움 리모숨 KCTC 3266이며, 상기 박테로이드 속 균주는 박테로이드 후라길리스 KCTC 3688이다.
More preferably from Clostridium sp of the present invention is Clostridium difficile silica (Clostridium difficile or Clostridium perfringens , and the strain of the genus Yubucketium of the present invention is Eubacterium limosum ), and the strain of the genus Bacteroides of the present invention is Bacteroides fragilis ). Most preferably, the clostridial genus strain is Clostridium difficile KCTC 5009 or Clostridium puffin genus KCTC 3269, the strain of the genus Yubucketium is Yubactherium limnem KCTC 3266, the strain of genus Bacteroides Is the bacteroid Fragilex KCTC 3688.

본 발명의 조성물에서 이용되는 감잎 추출물은 감잎에 추출용매를 처리하여 수득하는 경우에는, 다양한 추출용매가 이용될 수 있다. 바람직하게는, 극성 용매 또는 비극성 용매를 이용할 수 있다. 극성 용매로서 적합한 것은, (i) 물, (ii) 알코올(바람직하게는, 메탄올, 에탄올, 프로판올, 부탄올, 노말-프로판올, 이소-프로판올, 노말-부탄올, 1-펜탄올, 2-부톡시에탄올 또는 에틸렌글리콜), (iii) 아세트산, (iv) DMFO(dimethyl-formamide) 및 (v) DMSO(dimethyl sulfoxide)를 포함한다. 비극성 용매로서 적합한 것은, 아세톤, 아세토나이트릴, 에틸 아세테이트, 메틸 아세테이트, 플루오로알칸, 펜탄, 헥산, 2,2,4-트리메틸펜탄, 데칸, 사이클로헥산, 사이클로펜탄, 디이소부틸렌, 1-펜텐, 1-클로로부탄, 1-클로로펜탄, o-자일렌, 디이소프로필 에테르, 2-클로로프로판, 톨루엔, 1-클로로프로판, 클로로벤젠, 벤젠, 디에틸 에테르, 디에틸 설파이드, 클로로포름, 디클로로메탄, 1,2-디클로로에탄, 어닐린, 디에틸아민, 에테르, 사염화탄소 및 THF를 포함한다.When the persimmon leaves used in the composition of the present invention are obtained by treating the persimmon leaves with the extraction solvent, various extraction solvents may be used. Preferably, a polar solvent or a non-polar solvent can be used. Suitable polar solvents are (i) water, (ii) alcohols (preferably methanol, ethanol, propanol, butanol, n-propanol, iso-propanol, n-butanol, 1-pentanol, Or ethylene glycol), (iii) acetic acid, (iv) dimethyl-formamide (DMFO) and (v) dimethyl sulfoxide (DMSO). Suitable nonpolar solvents are acetone, acetonitrile, ethyl acetate, methyl acetate, fluoroalkane, pentane, hexane, 2,2,4-trimethylpentane, decane, cyclohexane, cyclopentane, diisobutylene, 1- But are not limited to, pentane, 1-chlorobutane, 1-chloropentane, o-xylene, diisopropyl ether, 2- chloropropane, toluene, 1- chloropropane, chlorobenzene, benzene, diethyl ether, diethylsulfide, Methane, 1,2-dichloroethane, aniline, diethylamine, ether, carbon tetrachloride, and THF.

보다 바람직하게는, 본 발명에서 이용되는 추출용매는 (a) 물, (b) 탄소수 1-4의 무수 또는 함수 저급 알코올(메탄올, 에탄올, 프로판올, 부탄올 등), (c) 상기 저급 알코올과 물과의 혼합용매, (d) 아세톤, (e) 에틸 아세테이트, (f) 클로로포름, (g) 부틸아세테이트, (h) 1,3-부틸렌글리콜, (i) 헥산 및 (j) 디에틸에테르를 포함한다. 가장 바람직하게는, 본 발명의 추출물은 물, 에탄올 또는 이의 조합을 감잎에 처리하여 수득한 것이다.More preferably, the extraction solvent used in the present invention is (a) water, (b) anhydrous or hydrated lower alcohol having 1 to 4 carbon atoms (methanol, ethanol, propanol, butanol, etc.) (E) ethyl acetate, (f) chloroform, (g) butyl acetate, (h) 1,3-butylene glycol, (i) hexane and (j) diethyl ether. . Most preferably, the extract of the present invention is obtained by treating water, ethanol or a combination thereof with persimmon leaves.

본 명세서에서 사용되는 용어 '추출물'은 상술한 바와 같이 당업계에서 조추출물(crude extract)로 통용되는 의미를 갖지만, 광의적으로는 추출물을 추가적으로 분획(fractionation)한 분획물도 포함한다. 즉, 감잎 추출물은 상술한 추출용매를 이용하여 얻은 것뿐만 아니라, 여기에 정제과정을 추가적으로 적용하여 얻은 것도 포함한다. 예컨대, 상기 추출물을 일정한 분자량 컷-오프 값을 갖는 한외 여과막을 통과시켜 얻은 분획, 다양한 크로마토그래피(크기, 전하, 소수성 또는 친화성에 따른 분리를 위해 제작된 것)에 의한 분리 등, 추가적으로 실시된 다양한 정제 방법을 통해 얻어진 분획도 본 발명의 감잎 추출물에 포함되는 것이다.As used herein, the term " extract " means that it is used in the art as a crude extract as described above, but broadly includes fractions obtained by further fractionating the extract. That is, the persimmon leaf extract includes not only those obtained by using the above-described extraction solvent but also those obtained by additionally applying a purification process thereto. For example, a fraction obtained by passing the above extract through an ultrafiltration membrane having a constant molecular weight cut-off value, and a separation by various chromatography (manufactured for separation according to size, charge, hydrophobicity or affinity) The fraction obtained through the purification method is also included in the persimmon leaf extract of the present invention.

본 발명에서 이용되는 감잎 추출물은 감압 증류 및 동결 건조 또는 분무 건조 등과 같은 추가적인 과정에 의해 분말 상태로 제조될 수 있다.The persimmon leaf extract used in the present invention may be prepared in powder form by an additional process such as vacuum distillation and freeze-drying or spray drying.

본 발명의 바람직한 구현예에 따르면, 본 발명의 감잎 추출물은 물 추출물과 에탄올 추출물의 혼합물이다. According to a preferred embodiment of the present invention, the persimmon leaf extract of the present invention is a mixture of a water extract and an ethanol extract.

보다 바람직하게는, 본 발명의 물 추출물은 장내 유익균의 증식을 촉진하고, 가장 바람직하게는 락토바실러스 속 또는 비피도박테리움 속의 배양 시작 시점으로부터 0.1-12 시 동안의 증식을 촉진하거나 스트렙토코커스 속의 배양 시작 시점으로부터 8-24 시 동안의 증식을 촉진한다.More preferably, the water extract of the present invention promotes the proliferation of beneficial bacteria in the intestines, and most preferably promotes the proliferation for 0.1-12 hours from the start of the culture of the genus Lactobacillus or Bifidobacterium, or cultivation of Streptococcus Promoting proliferation for 8-24 hours from the start.

보다 바람직하게는, 본 발명의 물 추출물은 유리당을 0.1-1.0 g/100g 함유하고, 보다 더 바람직하게는 0.1-0.7 g/100g 함유하며, 보다 더욱 더 바람직하게는 0.3-0.7 g/100g 함유하고, 가장 바람직하게는 0.4-0.6 g/100g 함유한다.More preferably, the water extract of the present invention contains 0.1-1.0 g / 100 g, more preferably 0.1-0.7 g / 100 g, still more preferably 0.3-0.7 g / 100 g of free sugar , Most preferably 0.4-0.6 g / 100 g.

보다 바람직하게는, 본 발명의 물 추출물은 폴리페놀을 3-15 mg/g 함유하고, 보다 더 바람직하게는 6-12 mg/g 함유하며, 가장 바람직하게는 7-11 mg/g 함유한다.More preferably, the water extract of the present invention contains 3-15 mg / g of polyphenol, more preferably 6-12 mg / g, and most preferably 7-11 mg / g.

보다 바람직하게는, 본 발명의 물 추출물은 플라보노이드를 30-60 μg/g 함유하고, 보다 더 바람직하게는 40-60 μg/g 함유하며, 보다 더욱 더 바람직하게는 45-55 μg/g 함유하고, 가장 바람직하게는 45-50 μg/g 함유한다.More preferably, the water extract of the present invention contains 30-60 μg / g, even more preferably 40-60 μg / g, even more preferably 45-55 μg / g of flavonoids , Most preferably 45-50 μg / g.

보다 바람직하게는, 본 발명의 물 추출물은 30-70%의 항산화 효능을 가지고, 보다 더 바람직하게는 40-60%의 항산화 효능을 가지며, 가장 바람직하게는 45-55%의 항산화 효능을 가진다.More preferably, the water extract of the present invention has an antioxidative effect of 30-70%, more preferably 40-60%, and most preferably 45-55%.

보다 바람직하게는, 본 발명의 에탄올 추출물은 장내 유해균의 생육을 억제한다. More preferably, the ethanol extract of the present invention inhibits the growth of harmful bacteria in the intestines.

보다 바람직하게는, 본 발명의 에탄올 추출물은 1-25 mg/mL에서 최소 저해농도를 가지고, 보다 더 바람직하게는 3-22 mg/mL에서 최소 저해농도를 가지며, 가장 바람직하게는 3-7 mg/mL 또는 18-22 mg/mL에서 최소 저해농도를 갖는다.More preferably, the ethanol extract of the present invention has a minimal inhibitory concentration at 1-25 mg / mL, even more preferably at a minimum inhibitory concentration at 3-22 mg / mL, most preferably 3-7 mg / mL or at a minimum inhibitory concentration of 18-22 mg / mL.

보다 바람직하게는, 본 발명의 에탄올 추출물은 유리당을 0.1-1.0 g/100g 함유하고, 보다 더 바람직하게는 0.1-0.8 g/100g 함유하며, 보다 더욱 더 바람직하게는 0.4-0.8 g/100g 함유하고, 가장 바람직하게는 0.5-0.5 g/100g 함유한다.More preferably, the ethanol extract of the present invention contains 0.1-1.0 g / 100 g, more preferably 0.1-0.8 g / 100 g, still more preferably 0.4-0.8 g / 100 g of free sugar , Most preferably 0.5-0.5 g / 100 g.

보다 바람직하게는, 본 발명의 에탄올 추출물은 폴리페놀을 3-15 mg/g 함유하고, 보다 더 바람직하게는 5-12 mg/g 함유하며, 가장 바람직하게는 7-10 mg/g 함유한다.More preferably, the ethanol extract of the present invention contains 3-15 mg / g of polyphenol, more preferably 5-12 mg / g, and most preferably 7-10 mg / g.

보다 바람직하게는, 본 발명의 에탄올 추출물은 플라보노이드를 10-40 μg/g 함유하고, 보다 더 바람직하게는 15-35 μg/g 함유하며, 보다 더욱 더 바람직하게는 20-30 μg/g 함유하고, 가장 바람직하게는 24-28 μg/g 함유한다.More preferably, the ethanol extract of the present invention contains 10-40 μg / g, even more preferably 15-35 μg / g, even more preferably 20-30 μg / g of flavonoids , And most preferably 24-28 μg / g.

보다 바람직하게는, 본 발명의 에탄올 추출물은 15-55%의 항산화 효능을 가지고, 보다 더 바람직하게는 25-45%의 항산화 효능을 가지며, 가장 바람직하게는 30-40%의 항산화 효능을 가진다.
More preferably, the ethanol extract of the present invention has an antioxidative effect of 15-55%, more preferably an antioxidative effect of 25-45%, and most preferably an antioxidative effect of 30-40%.

본 발명의 특징 및 이점을 요약하면 다음과 같다: The features and advantages of the present invention are summarized as follows:

(a) 본 발명은 감잎 추출물을 포함하는 프리바이오틱스을 제공한다.(a) The present invention provides a prebiotics comprising persimmon leaf extract.

(b) 본 발명은 감잎의 물 추출물을 처리하여 장내 유익균을 증식시키고, 감잎의 에탄올 추출물을 처리하여 장내 유해균의 생육을 억제할 수 있어 감잎 추출물을 포함하는 프리바이오틱스에 의하여 장내 유익균 및 유해균의 생육을 모두 조절할 수 있는 이점이 있다. (b) According to the present invention, the water extract of persimmon leaves is treated to proliferate beneficial bacteria in the intestines, and the ethanol extract of persimmon leaves can be treated to inhibit the growth of harmful bacteria in the intestines. Thus, the prebiotics including persimmon leaves extract There is an advantage that all the growth can be controlled.

(b) 본 발명의 감잎 추출물은 우수한 전자공여능을 갖는바 항산화 작용도 가능한 이점이 있다.
(b) The persimmon leaf extract of the present invention has an excellent electron donating ability and also has an advantage of antioxidative action.

도 1a 내지 1c는 감잎 추출물이 락토바실러스 루테리 KCTC 3594(1a), 스트렙토코커스 서머필러스 KCTC 3658(1b) 및 비피도박테리움 아돌레센티스 KCTC 3352(1c)의 증식에 미치는 효과를 나타낸다.
도 2는 감잎 추출물의 DPPH 자유 라디칼 소거능에 의한 항산화 활성을 나타낸다.
FIGS. 1A to 1C show the effects of the persimmon leaf extract on the proliferation of Lactobacillus luteri KCTC 3594 (1a), Streptococcus thermophilus KCTC 3658 (1b) and Bifidobacterium adiales KCTC 3352 (1c).
Fig. 2 shows antioxidant activity of DPPH free radical scavenging ability of persimmon leaf extract.

이하, 실시예를 통하여 본 발명을 더욱 상세히 설명하고자 한다. 이들 실시예는 오로지 본 발명을 보다 구체적으로 설명하기 위한 것으로, 본 발명의 요지에 따라 본 발명의 범위가 이들 실시예에 의해 제한되지 않는다는 것은 당업계에서 통상의 지식을 가진 자에 있어서 자명할 것이다.
Hereinafter, the present invention will be described in more detail with reference to Examples. It is to be understood by those skilled in the art that these embodiments are only for describing the present invention in more detail and that the scope of the present invention is not limited by these embodiments in accordance with the gist of the present invention .

실시예Example

본 명세서 전체에 걸쳐, 특정 물질의 농도를 나타내기 위하여 사용되는 "%"는 별도의 언급이 없는 경우, 고체/고체는 (중량/중량)%, 고체/액체는 (중량/부피)%, 그리고 액체/액체는 (부피/부피)%이다.
Throughout this specification, "%" used to denote the concentration of a particular substance is intended to include solids / solids (wt / wt), solid / liquid (wt / The liquid / liquid is (vol / vol)%.

실험 방법 및 실험 재료Experimental Methods and Materials

시료 및 사용 균주Samples and strains used

본 실험에서 사용한 감잎 분말은 경북 청송군에서 재배한 것을 동결건조한 것으로 (주)백장생에서 구입하여 사용하였다. 균주는 한국생물자원센터(KCTC: Korean Collection for Type cultures, 대한민국)에서 분양 받았으며, 장내 유해균으로는 클로스트리디움 디피실리 KCTC 5009, 클로스트리디움 퍼프린젠스 KCTC 3269, 유박테리움 리모숨 KCTC 3266, 박테로이드 후라길리스 KCTC 3688을 사용하였다. 장내 유래 유익균은 비피도박테리움 아돌레센티스 KCTC 3352, 락토바실러스 루테리 KCTC 3594, 스트렙토코커스 서머필러스 KCTC 3658을 사용하였다. 장내 유해균을 배양하기 위하여 RCM(Reinforced Clostridial Medium) 브로스(디프코社, 미국)를 전배양 및 본배양을 위한 증식배지로 사용하였으며, 장내 유해균들은 37℃ 혐기성 조건하에서 48시간 동안 배양하였다. 장내 유익균을 배양하기 위한 증식배지로는 락토바실리(Lactobacilli) MRS 브로스(디프코社, 미국)를 사용하였으며, 균주는 실험에 사용하기 전 3회 이상 계대 배양하여 활성화시킨 후 사용하였다.
The persimmon leaf powder used in this experiment was purchased from Baekjangsyo Co., Ltd., which was lyophilized from Cheongsong-gun, Gyeongbuk. The strains were distributed from KCTC (Korea Collection for Type cultures, Korea). Enteric bacteria were enteric bacteria such as Clostridium difficile KCTC 5009, Clostridium perfringens KCTC 3269, Yubactherium remnant KCTC 3266, Bacteroides Fragilis KCTC 3688 was used. Bifidobacterium adolescentis KCTC 3352, Lactobacillus luteri KCTC 3594, and Streptococcus thermophilus KCTC 3658 were used as the beneficial bacteria derived from intestines. RCM (Reinforced Clostridial Medium) broth (Difco, USA) was used as a propagation medium for preincubation and main culture to cultivate enteric bacteria in the intestines, and the intestinal noxious bacteria were incubated for 48 hours under anaerobic conditions at 37 ° C. Lactobacilli MRS broth (Dipco, USA) was used as a growth medium for culture of intestinal beneficial bacteria, and the strain was used after being subcultured for 3 or more times before use in the experiment.

감잎추출Persimmon leaf extract 방법 Way

감잎 용매별 추출물은 물과 80% EtOH을 이용하였다. 감잎분말 200 g에 증류수 1,000 mL를 넣고 항온수조(water bath)에서 70℃로 10분 동안 중탕 처리하여 3차 추출물을 얻었다. 감잎 물 추출물을 여과지(Whatman No.2)로 거른 후 동결건조기(EYELA FDU-2100, 일본)에서 건조하여 사용하였다. 또한 감잎분말에 80% EtOH을 이용하여 위의 방법으로 추출물을 사용하였다. 건조된 시료는 -40℃ 냉동고에 보관하였다.
Water and 80% EtOH were used as extracts of the persimmon leaves. 1,000 g of distilled water was added to 200 g of the persimmon leaf powder and the mixture was treated with hot water at 70 ° C for 10 minutes in a water bath to obtain a third extract. The persimmon leaf extract was filtered with filter paper (Whatman No. 2) and dried in a freeze dryer (EYELA FDU-2100, Japan). In addition, 80% EtOH was used for the persimmon leaf powder and the extract was used by the above method. The dried samples were stored in a -40 ° C freezer.

감잎 추출물이 장내 Persimmon leaves extract 유익균Beneficial bacteria 증식에 미치는 영향 Effect on proliferation

생성된 집락수를 계측하고 그 평균 집락수에 희석배수를 곱하여 배양액 mL당 생균수를 산출하였다. 5 mL MRS 브로스에 감잎 추출 분말(물 추출물 및 에탄올 추출물)을 각각 1 (v/w)%씩 첨가한 후 멸균하여 사용하였다. 멸균한 5 mL MRS 브로스 배지에 시험균(비피도박테리움 아돌레센티스 KCTC 3352, 락토바실러스 루테리 KCTC 3594 및 스트렙토코커스 서머필러스 KCTC 3658)을 660 nm 흡광도(optical density) 값이 0.30이 되도록 균 농도를 조절하여 100 μL를 접종한 후 37℃에서 배양하여 0, 4, 8, 12, 16, 20 및 24시간 간격으로 균수를 측정하였다. 대조군은 감잎추출물을 첨가하지 않은 MRS 브로스를 사용하였다.
The number of generated colonies was counted, and the average number of colonies was multiplied by a dilution factor to calculate the number of viable cells per mL of the culture. To the 5 mL MRS broth, 1 (v / w)% each of persimmon leaf extract powder (water extract and ethanol extract) was added and sterilized. The test bacteria (Bifidobacterium adolescentis KCTC 3352, Lactobacillus luteri KCTC 3594 and Streptococcus thermophilus KCTC 3658) were added to sterile 5 mL MRS broth medium to a concentration of 660 nm optical density of 0.30 , And then cultured at 37 ° C. The number of bacteria was measured at 0, 4, 8, 12, 16, 20 and 24 hours intervals. Control group was MRS broth without added persimmon leaf extract.

감잎 추출물의 장내 유해균 생육에 미치는 영향Effect of Persimmon Leaf Extract on the Growth of Intestinal Pests

미생물의 최소저해농도(MIC: Minimum Inhibitory Concentration)는 브로스 마이크로딜루션 방법을 응용하여 다음과 같이 측정하였다. 24시간 배양된 세균 배양액을 650 nm에서 흡광도가 0.3이 되게 조절한 후 96 웰 플레이트에 각 시험균 배양액을 160 μL 씩 분주하고 감잎 추출물의 최종농도가 20, 10, 5 및 1 mg/ml가 되도록 40 μL 첨가한 후 24시간 혐기 배양하였다. 세균의 성장은 650 mn에서 ELISA 리더로 측정하였다. 대조군으로는 시료 대신 30% DMSO를 사용하였으며, 실험은 8회 이상 반복 실시하였다.
The minimum inhibitory concentration (MIC) of microorganisms was determined by applying the broth microdissolution method as follows. After culturing the culture medium for 24 hours at 650 nm, the absorbance was adjusted to 0.3, and 160 μL of each culture medium was dispensed into a 96-well plate. The final concentration of the persimmon leaf extract was adjusted to 20, 10, 5 and 1 mg / ml 40 μL was added and then anaerobically cultured for 24 hours. Bacterial growth was measured with an ELISA reader at 650 mn. As a control, 30% DMSO was used instead of the sample, and the experiment was repeated 8 times or more.

감잎 추출물의 유리당 분석Free Sugar Analysis of Persimmon Leaf Extract

감잎 추출물을 물로 용해시킨 후 아세토니트릴(acetonitrile)을 첨가하고 0.45 μm 필터로 여과하여 HPLC 주입시료로 사용하였다. HPLC는 자스코 RI2031플러스(4.6 mm × 250 mm, 5 μm, 일본)를 이용하였으며, 카보하이드레이트 칼럼(30ⅹ300 mm, 워터스社)를 사용하였다. 이동상은 CH3CN:H2O(80:20, v/v)으로, 유속은 1.0 mL/min으로 하였고, 표준용액으로 검량곡선을 작성하여 추출물 중의 개별 당 함량을 정량하였다.
The persimmon leaf extract was dissolved in water, added with acetonitrile, filtered through a 0.45 μm filter, and used as an HPLC injection sample. HPLC was performed using a JASCO RI2031 Plus (4.6 mm x 250 mm, 5 μm, Japan) and a carbohydrate column (30 x 300 mm, Waters). The mobile phase was CH 3 CN: H 2 O (80:20, v / v) and the flow rate was 1.0 mL / min. A calibration curve was prepared with the standard solution to quantify the individual sugar content of the extract.

감잎 추출물의 총 폴리페놀 함량 측정Total Polyphenol Content of Persimmon Leaf Extract

감잎 추출물의 총 폴리페놀 화합물의 함량을 측정하기 위하여 페놀성 물질이 포스포몰리브덴산(phosphomolybdic acid)과 반응하여 청색을 나타내는 것을 이용한 폴린 데니스(Folin Deinis)법(AOAC., Association of official analytical chemists, Offical methods of analysis. 15th ed., Washington DC. Cd 8-35 (1990))을 일부 변형하여 비색정량을 실시하였다. 감잎 추출액 100 μL에 증류수 5 mL 첨가하여 섞은 후 50 μL의 폴린-시오칼토 시약(Folin-Ciocalteu reagent)을 혼합하였다. 여기에 포화 Na2CO3 1.5 mL와 증류수 2.9 mL를 첨가하여 실온에서 2시간 방치한 후 765 nm에서 흡광도를 측정하였으며 표준물질로는 갈산(gallic acid, 시그마社, 미국)을 사용하였다.
The Folin Deinis method (AOAC, Association of official analytical chemists, AOAC) using a phenolic substance reacting with phosphomolybdic acid to give a blue color to determine the total polyphenol compound content of Persimmon leaf extract. Offical methods of analysis . 15th ed., Washington DC. Cd 8-35 (1990)) was partially modified to perform colorimetric determination. 5 mL of distilled water was added to 100 μL of persimmon leaf extract, and 50 μL of Folin-Ciocalteu reagent was mixed. After adding 1.5 mL of saturated Na 2 CO 3 and 2.9 mL of distilled water, the absorbance was measured at 765 nm after standing at room temperature for 2 hours. Gallic acid (Sigma, USA) was used as a reference material.

감잎추출물의Persimmon leaf extract 총 플라보노이드 함량 측정  Total flavonoid content measurement

감잎추출물의 총 플라보노이드 함량 측정은 모레노(Moreno) 등(Moreno MIN et al., J Ethnopharmacol, Comparison of the free radical scavenging activity of propolis from several regions of Argentina ., 71:109-114(2000))의 방법을 이용하였다. 감잎 추출액 100 μg에 2% 질산 알루미늄(aluminum nitrate) 100 μL를 혼합하고 실온에서 10분간 방치한 다음 430 nm에서 흡광도를 측정하였다. 이때 표준물질은 쿼세틴(Quercetin, 시그마社, 미국)을 사용하였다.
And total flavonoid content measurement of the persimmon leaf extract is Moreno (Moreno) (Moreno MIN et al ., J Ethnopharmacol, Comparison of the free radical scavenging activity of propolis from several regions of Argentina . , 71: 109-114 (2000)). 100 μg of persimmon leaf extract was mixed with 2 μl of aluminum nitrate (100 μl), left at room temperature for 10 minutes, and then absorbed at 430 nm. At this time, quercetin (Quercetin, Sigma, USA) was used as a reference material.

감잎추출물의Persimmon leaf extract DDPHDDPH 라디칼Radical 소거능Scatters 시험  exam

DPPH(α,α-diphenyl-β-picrylhydrazyl) 라디칼에 대한 소거활성은 블루아 등의 방법(Blios MS et al., Nature, Antioxidant determination by the use of stable free radicals. 181:1199??1200(1958))에 따라 시험하였다. 에탄올 2.8 mL에 감잎추출물 0.4 mL와 4×10-4 M DPPH 용액 0.8 mL를 가하여 10초 동안 혼합한 후 10분 동안 실온에서 방치한 뒤 525 nm에서 흡광도를 측정하였다. 대조구로는 비타민 C(아스코르브산, 시그마社, 미국)를 사용하였다.
The scavenging activity for DPPH (α, α-diphenyl-β-picrylhydrazyl) radicals was determined by the method of Blios et al. et al., Nature,Antioxidant determination by the use of stable free radicals. 181: 1199 ?? 1200 (1958)). To 2.8 mL of ethanol, add 0.4 mL of persimmon leaf extract and 4 x 10-4 M DPPH solution was added and mixed for 10 seconds. The mixture was allowed to stand at room temperature for 10 minutes and absorbance was measured at 525 nm. Vitamin C (ascorbic acid, Sigma, USA) was used as a control.

결과 및 고찰 Results and Discussion

감잎추출물이Persimmon leaf extract 장내  Intestines 유익균Beneficial bacteria 증식에 미치는 영향 Effect on proliferation

감잎 추출물과 장내 유익균 증식과의 관계는 도 1와 같다. 락토바실러스 루테리의 경우, 12시간까지는 감잎 물 추출물이 균 증식에 효과를 보였으나 12시간 이후에는 대조군과 크게 차이가 없는 것으로 나타났다. 스트렙토코커스 서머필러스의 경우 초기 증식에 감잎 추출물의 효과가 없었으나 8시간부터 물 추출물에서 균 증식에 효과를 보이는 것으로 나타났다. 또한 감잎 물 추출물은 비피도박테리움 아돌레센티스에서 균 증식에 효과를 보였으나 12시간 이후부터는 균 증식에 별다른 효과가 없는 것으로 나타났다. 이러한 결과들을 볼 때 감잎은 장내 유익균의 성장을 촉진시키며, 물 추출물이 에탄올 추출물보다 더 효과적이라는 것을 알 수 있었다. 정 등의 연구(Jeong et al., J Korean Soc Food Sci Nutr, Effects of Zizyphus jujuba var . boeunesis Extracts on the Growth of Intestinal Microflora and Its Antioxidant Activities, 40(4), 500-508(2011)))의 추출물을 이용하여 장내 미생물 증식을 살펴본 결과 초기의 흡광도는 높았지만 대수기에 도달하였을 때의 흡광도는 대조군과 장내 유익균에서는 별다른 영향을 미치지 않는 것으로 나타났다. The relationship between the persimmon leaf extract and the intestinal beneficial bacteria proliferation is shown in Fig. In the case of Lactobacillus lutea, the deciduous water extract showed an effect on the mycosis proliferation up to 12 hours, but not significantly after 12 hours. In the case of Streptococcus thermophilus, the effect of persimmon leaf extract on the initial proliferation was not observed, but it was effective in the proliferation of the water extract from 8 hours. In addition, the extract of Persimmon leaves showed an effect on the growth of bacteria in Bifidobacterium adolescentis, but after 12 hours, there was no effect on the growth of bacteria. These results suggest that persimmon leaves stimulate the growth of beneficial bacteria in the intestines and that water extracts are more effective than ethanol extracts. Jung et al., J Korean Soc Food Sci Nutr, Effects of Zizyphus jujuba there is . boeunesis Extracts on the Growth of Intestinal Microflora and Its Antioxidant Activities , 40 (4), 500-508 (2011))) were used to investigate intestinal microbial proliferation. The initial absorbance was high, but the absorbance at the time of reaching the greatest stage had little effect on the control and intestinal bacteria. .

우 등은 감잎 물 추출물 10% 첨가가 장내 유래 유산균이 아닌 일반 유산균(락토바실러스 애시도필러스 MG501, 락토바실러스 브레비스 MG19, 락토바실러스 불가리쿠스 MG515, 락토바실러스 락티스 MG530, 락토바실러스 카세이 MG311) 증식에 효과적이라고 보고하였다(Woo et al., Korean J. Food & Nutr, Studies on Antioxidative Effect and Lactic Acid Bacteria Growth of Persimmon Leaf Extracts, 18(1): 28-38(2005)). 감잎 1% 첨가를 살펴본 본 연구와는 달리 우 등의 연구에는 감잎 추출물을 고농도(10%)로 첨가하였으며, 본 연구에서는 감잎 추출물의 첨가가 일반 유산균이 아닌 장내 유익균 성장에 도움을 주는 것을 알 수 있었다.
The addition of 10% of the persimmon leaf water extract to the growth of common lactic acid bacteria (Lactobacillus acidophilus MG501, Lactobacillus brevis MG19, Lactobacillus bulgaricus MG515, Lactobacillus lactis MG530, Lactobacillus casei MG311) (Woo et al., Korean J. Food & Nutr, Studies on Antioxidative Effect and Lactic Acid Bacteria Growth of Persimmon Leaf Extracts , 18 (1): 28-38 (2005)). In contrast to the present study in which 1% of persimmon leaves were added, the persimmon leaf extract was added at a high concentration (10%) in the study of Wu et al. In this study, it was found that the addition of persimmon leaves extract helps the growth of beneficial bacteria in the intestines there was.

감잎 추출물이 장내 유해균 생육에 미치는 영향Effect of Persimmon Leaf Extract on the Growth of Enteric Bacteria in the Intestine

감잎 추출물의 장내 유해균에 대한 최소저해농도(MIC: Minimum Inhibitory Concentration) 측정은 감잎 물 추출물과 에탄올 추출물의 MIC를 측정하였다(표 1). 감잎 물 추출물의 경우 클로스트리디움 디피실리, 클로스트리디움 퍼프린젠스, 유박테리움 리모숨, 박테로이드 후라길리스 모든 균주에서 20 mg/mL에서도 미생물 증식이 일어났으나, 감잎 에탄올 추출물의 경우는 클로스트리디움 디피실리, 클로스트리디움 퍼프린젠스, 박테로이드 후라길리스에서는 5 mg/mL 농도에서부터, 유박테리움 리모숨 경우 10 g/mL 농도에서부터 생육이 저해되어 표 1과 같은 MIC를 나타내었다. 따라서 전체적으로 MIC 결과를 분석해보면 감잎 에탄올 추출물이 물 추출물보다 높은 유해균 생육 억제활성을 나타냄을 알 수 있었다.
MIC (Minimum Inhibitory Concentration) of persimmon leaves extracts were measured by MIC of persimmon leaf extract and ethanol extract (Table 1). Microbial proliferation was observed at 20 mg / mL in all strains of Clostridium difficile, Clostridium perfringens, Eubacterium limmoth, and Bacteroides fulgillis in the case of the persimmon leaf water extract. In the case of the persimmon leaf ethanol extract, however, Growth was inhibited at a concentration of 5 mg / mL in Clostridium difficile, Clostridium perfringens and Bacteroides furigillis, and at a concentration of 10 g / mL in case of Streptococcus pneumoniae, and the MIC was shown in Table 1 . As a result, it was found that the ethanol extract of persimmon leaves exhibited a higher inhibitory effect on the growth of harmful bacteria than the water extract.

감잎 추출물에 의한 MIC(Minimum inhibitory concentration)Minimum inhibitory concentration (MIC) StrainStrain 농도별 생장(mg/mL)Growth by concentration (mg / mL) MICMIC 1.01.0 5.05.0 10.010.0 20.020.0 (mg/mL)(mg / mL) 클로스트리디움 디피실리Clostridium difficile water +1) + 1) ++ + + ++ -- EotHEotH ++ -2) - 2) -- -- 5.05.0 클로스트리디움 퍼프린젠스Clostridium perfringens water ++ ++ ++ ++ -- EotHEotH ++ -- -- -- 5.05.0 유박테리움
리모숨
Yubat Terium
Limo-breath
water ++ ++ ++ ++ --
EotHEotH ++ ++ -- -- 10.010.0 박테로이드
후라길리스
Bacteroid
Furagillis
water ++ ++ ++ ++ --
EotHEotH ++ -- -- -- 5.05.0

1): 저해하지 않음, 2): 저해
1) : not inhibited, 2) : inhibited

감잎 추출물의 유리당 분석Free Sugar Analysis of Persimmon Leaf Extract

HPLC를 이용한 감잎 추출물의 유리당 분석은 표 1과 같다. 감잎 80% 에탄올 추출물의 프럭토오스(fructose), 글루코오스(glucose) 및 수크로오스(sucrose)함량을 분석한 결과는 각각 0.30, 0.21 및 0.11 g/100g로 나타났으며, 감잎 열수 추출물에서는 0.25, 0.19 및 0.06 g/100g의 함량을 보였다.The free sugar analysis of the persimmon leaf extract by HPLC is shown in Table 1. The contents of fructose, glucose and sucrose in the 80% ethanol extract of persimmon leaves were 0.30, 0.21 and 0.11 g / 100g, respectively, and 0.25 and 0.19, respectively, 0.06 g / 100 g.

오 등의 연구(Oh et al., J Korean Soc Food Sci Nutr, Effects of Artemisia capillaris Extracts on Intestinal Microflora In vitro and In vivo, 39(11), 1587-1594(2010))에서 프럭토오스, 글루코오스 및 수크로오스 등과 같은 유리당의 함량이 높을수록 유산균에 의한 발효가 촉진된다고 보고되었으며, 정 등의 연구(Jeong et al. J Korean Soc Food Sci Nutr, Effects of Zizyphus jujuba var. boeunesis Extracts on the Growth of Intestinal Microflora and Its Antioxidant Activities. 40(4), 500-508(2011))에서도 대추 추출물에 존재하는 당이 프리바이오틱스로 작용하여 증진효과가 있는 것으로 보고하였다. 그러나 본 연구에서는 감잎 추출물 내의 유리당 함량이 비교적 낮아 당에 의한 장내 유익균 성장 효과가 적을 것으로 사료된다.Oh et al., J Korean Soc Food Sci Nutr, Effects of Artemisia capillaris Extracts on Intestinal Microflora In vitro and In vivo, 39 (11), 1587-1594 The higher the content of free sugar, such as (2010)) from fructose, glucose and sucrose has been reported to promote the fermentation by lactic acid bacteria, study information such as (Jeong et al. J Korean Soc Food Sci Nutr, Effects of Zizyphus I have jujuba . boeunesis Extracts on the Growth of Intestinal Microflora and Its Antioxidant Activities . 40 (4), 500-508 (2011)) also reported that the sugars present in the jujube extract act as prebiotics and thus have an enhancing effect. However, the free sugar content of persimmon leaves was relatively low in this study.

감잎 추출물(g/100g) 내 유리당 조성Free sugar composition in persimmon leaf extract (g / 100 g) 샘플Sample 프럭토오스Fructose 글루코오스Glucose 수크로오스Sucrose 물 추출물Water extract 0.251) 0.25 1) 0.190.19 0.060.06 80% EtOH 추출물80% EtOH extract 0.300.30 0.210.21 0.110.11

1): 실험 방법 및 실험 재료에 개시된 HPLC 분석에 따라 결정된 유리당 함량. 각각의 값은 3회 반복 실험에 따른 결과의 평균을 나타냄(S.D.= 0.002 이하).
1) : Free sugar content determined according to the HPLC method described in the Experimental Methods and Materials. Each value represents the average of the results from three repeated experiments (SD = 0.002 or less).

감잎 추출물의 총 폴리페놀함량Total polyphenol content of persimmon leaf extract

감잎의 추출방법에 따른 총 폴리페놀 함량은 표 2와 같다. 갈산을 표준물질로 사용하였을 때 감잎 열수 추출물의 폴리페놀 함량의 폴리페놀 함량은 8.86 mg/g이었다. 감잎 에탄올 추출물의 경우 8.32 mg/g로 나타나 추출용매에 따른 총 폴리페놀 함량은 유의적 차이가 없었다. 카페산(Caffeic acid)를 표준물질로 사용하여 총 폴리페놀 함량을 구한 정 등 연구에서 감잎 물 추출물의 총 폴리페놀 함량은 25.30-148.25 mg/100g이었다. 반면 카테킨(Catechin)을 표준물질로 사용하여 감잎의 수확시기에 따른 총 폴리페놀 함량을 구한 연구(Jung et al., Korean Journal of Food Preservation, Chemical Components and Antioxidant Activity of Persimmon(Diospyros Kaki Thunb ) Leaves, 11(2):175-181(2004))에서는 감잎 에탄올 추출물의 폴리페놀 함량의 범위가 넓었으며(105.7-182.2 mg/g), 표준물질에 따른 총 폴리페놀 함량은 차이 확연하게 나타났다.
Table 2 shows the total polyphenol contents of the persimmon leaves. When gallic acid was used as a standard substance, the polyphenol content of the persimmon leaf hot water extract was 8.86 mg / g. And 8.32 mg / g for persimmon leaf ethanol extract. Total polyphenol contents were not significantly different according to the extraction solvent. The total polyphenol content of the persimmon leaves extract was found to be 25.30-148.25 mg / 100g in a study of the total polyphenol contents obtained using caffeic acid as a standard material. In contrast, when catechin was used as a standard material, the total polyphenol content of the persimmon leaves was determined by harvesting time (Jung et al., J Korean J. Rep. Of Food Preservation, Chemical Components and Antioxidant Activity of Persimmon (Diospyros Kaki Thunb) Leaves, 11 (2) : 175-181 (2004)) was in the range of the polyphenol content of the extract of persimmon leaves ethanol was wide (105.7-182.2 mg / g), the total polyphenol content of the reference material is evident difference appear.

감잎 추출물의 총 플라보노이드 함량Total flavonoid content of persimmon leaf extract

쿼세틴을 표준물질로 사용하였을 때 감잎열수 추출물의 플라보노이드 함량은 47.59 μg/g로 나타났다. 에탄올 추출물의 경우 25.81 μg/g로 이었다. 쿼세틴을 표준물질로 사용하여 총 플라보노이드 함량을 구한 라 등의 연구(Ra et al., Journal of Agriculture & Life Science, Effects of Cactus Extracts on Human Intestinal Microflora, 43(3):45-54(2009))에서 선인장 추출물의 플라보이드 함량은 1.04-2.10 mg/g이었다. 또한 추출물별 인진쑥의 플라보노이드 함량은 에탄올 추출물 1.20 mg/10g, 헥산 추출물 0.12 mg/10g, 클로르포름 추출물 0.28 mg/10g, 에틸아세테이트 추출물 1.91 mg/10g, 부탄올 추출물 0.34 mg/10g, 물 추출물 0.14 mg/10g로 용매 추출물별 차이가 있는 것으로 나타났다.When quercetin was used as a standard, the flavonoid content of persimmon leaf hot water extract was 47.59 μg / g. And 25.81 μg / g for ethanol extracts. (R) et al., Journal of Agriculture & Life Science, Effects , Vol. of Cactus Extracts on Human Intestinal Microflora , 43 (3): 45-54 (2009)), the flavonoid content of the cactus extract was 1.04-2.10 mg / g. The flavonoid contents of the extracts were 1.20 mg / 10 g of ethanol extract, 0.12 mg / 10 g of hexane extract, 0.28 mg / 10 g of chloroform extract, 1.91 mg / 10 g of ethyl acetate extract, 0.34 mg / 10 g of butanol extract, 10g, respectively.

감잎 추출물 내 총 폴리페놀 및 플라보노이드 농도Total Polyphenol and Flavonoid Concentration in Persimmon Leaf Extract 샘플Sample 총 폴리페놀(mg/g)1 ) Total polyphenol (mg / g) 1 ) 총 플라보노이드(μg/g)2 ) Total flavonoid (μg / g) 2 ) 물 추출물Water extract 8.96 ± 0.008.96 ± 0.00 47.59 ± 0.9447.59 + - 0.94 80% EtOH 추출물80% EtOH extract 8.32 ± 0.008.32 ± 0.00 25.81 ± 0.0025.81 ± 0.00

1): 갈산을 표준물질로 사용하였을 때 감잎 추출물 1 g당 총 폴리페놀 1) : When gallic acid was used as a standard substance, total polyphenol

2): 쿼세틴을 표준물질로 사용하였을 때 감잎 추출물 1 g당 총 플라보노이드
2) : When quercetin was used as a standard substance, total flavonoid

DPPHDPPH 라디칼Radical 소거능Scatters 시험 exam

DPPH법은 안정한 자유라디칼인 DPPH가 수소공여체(H-donor)와 반응하는 능력을 바탕으로 측정하는 방법이다. DPPH는 비교적 안정한 자유라디칼로서, 항산화 물질에 의해 환원되어 변색되므로 항산화 효능을 측정할 때 많이 이용된다. 대조구로 천연항산화제인 아스코르브산(95.92%, 시그마社)를 사용하여 DPPH 자유 라디칼 소거능에 의한 항산화 활성을 검색한 결과는 도 2로 나타났다. 대조군의 농도가 100 ppm 이었을 때 감잎 열수 추출물의 항산화 효능이 49.06%로 높게 나타났으며, 감잎 에탄올 추출물도 33.66%로 나타나 감잎 추출물이 우수한 전자공여능을 나타냈다. 또한, 감잎 추출물은 농도가 높을수록 우수한 전자공여능을 나타냈다. 따라서 감잎 추출물이 장내 유익균을 증진시킬 뿐 아니라 항산화 활성 역시 우수할 것으로 판단된다.
The DPPH method is based on the ability of DPPH, a stable free radical, to react with a hydrogen donor (H-donor). DPPH is a relatively stable free radical, which is reduced by antioxidants and discolored, so it is widely used for measuring antioxidant efficacy. As a control, antioxidant activity by DPPH free radical scavenging activity was ascertained using ascorbic acid (95.92%, Sigma) as a natural antioxidant. The antioxidant activity of persimmon leaf extract was high at 49.06% and that of persimmon leaf ethanol was 33.66% when the concentration of control was 100 ppm. The persimmon leaf extract showed excellent electron donating ability. In addition, the higher the concentration of persimmon leaf extract, the better the electron donating ability. Therefore, the persimmon leaf extract not only promotes beneficial bacteria in the intestines but also has antioxidant activity.

요약summary

본 연구는 감잎 추출물과 장내 유익균(락토바실러스 루테리 KCTC 3594, 스트렙토코커스 서머필러스 KCTC 3658, 비피도박테리움 아돌레센티스 KCTC 3352)의 증식에 미치는 영향을 알아보고자 하였다. 또한 증식인자를 알아보기 위하여 유리당 함량과 조성, 총 폴리페놀 함량, 총 플라보노이드 함량 및 DDPH 라디칼 소거능을 측정하는 시험을 하였다. 감잎 물 추출물이 장내 유익균 락토바실러스 루테리, 비피도박테리움 아돌레센티스에서 초기 장내 유익균 증식에 효과를 보였으며, 스트렙토코커스 서머필러스의 경우 8시간 이후부터 유익균 증식에 효과가 보였다. 유리당 함량은 에탄올 감잎추출물이 열수 추출물보다 높게 나타났으나 함량이 매우 적은 것으로 나타났다. 그리고 총 폴리페놀함량은 열수 추출물과 에탄올 추출물간의 유의적 차이가 없는 것으로 나타났으며, 총 폴리페놀함량은 열수 추출물이 에탄올 추출물보다 높게 나타났다. DPPH 자유 라디칼 소거능에 의한 항산화 활성을 검색한 결과 감잎 물 추출물의 이 에탄올 추출보다 높을수록 우수한 전자공여능을 나타냈다.
This study was carried out to investigate the effects of persimmon leaf extract and intestinal bacteria (Lactobacillus luterium KCTC 3594, Streptococcus thermophilus KCTC 3658, Bifidobacterium adolescentis KCTC 3352) on growth. To determine the growth factors, free sugar content, total polyphenol content, total flavonoid content and DDPH radical scavenging activity were measured. In the case of Streptococcus thermophilus, the extract of the persimmon leaves showed an effect on the proliferation of the beneficial bacteria in the intestinal flora in the intestinal lactic acid bacteria Lactobacillus lutea and Bifidobacterium adolescentis. The free sugar content of ethanol extract of persimmon leaves was higher than that of hot water extract, but the content of free sugar was very low. And total polyphenol contents were not significantly different between hot water extract and ethanol extract. Total polyphenol contents were higher than hot water extract and ethanol extract. The antioxidant activity of DPPH radical scavenging activity was higher than that of the decanter water extract.

이상으로 본 발명의 특정한 부분을 상세히 기술하였는바, 당업계의 통상의 지식을 가진 자에게 있어서 이러한 구체적인 기술은 단지 바람직한 구현 예일 뿐이며, 이에 본 발명의 범위가 제한되는 것이 아닌 점은 명백하다. 따라서 본 발명의 실질적인 범위는 첨부된 청구항과 그의 등가물에 의하여 정의된다고 할 것이다.
While the present invention has been particularly shown and described with reference to exemplary embodiments thereof, it is to be understood that the same is by way of illustration and example only and is not to be construed as limiting the scope of the present invention. It is therefore intended that the scope of the invention be defined by the claims appended hereto and their equivalents.

참고문헌references

1. An BJ, Choi HJ, Son JH, Woo HS, Park JH, Son GM,, Choi C (2003) Identification of biological effect and chemical structure of polyphenol compounds from the leaves of Korean persimmon (Diospyrus kaki L. Folium). Korean J Food Culture 18 : 443-4561. Identification of biological effects and chemical structure of polyphenol compounds from the leaves of Korean persimmon (Diospyrus kaki L. Folium). Korean J Food Culture 18: 443-456

2. Bae DK, Choi HJ, Son JH, Park MH, Bae JH, An BJ, Bae MJ, Choi C (2000) The study of developing and stability of functional beveragefrom Korean persimmon (Diospyrus kaki L. Folium) leaf. Korean J Food Sci Technol 32: 860-8662. Bae DK, Choi HJ, Son JH, Park MH, Bae JH, An BJ, Bae MJ, Choi C (2000) The study of developing and functional beveragefrom Korean persimmon (Diospyrus kaki L. Folium) leaf. Korean J Food Sci Technol 32: 860-866

3. Bo-Hyun Ra, Woon-Jong Lee, Yun-Won Cho, Kwang-Tup Kim. (2009) Effects of Cactus Extracts on Human Intestinal Microflora. Journal of Agriculture & Life Science Vol. 43, No. 3, pp. 45-543. Bo-Hyun Ra, Woon-Jong Lee, Yun-Won Cho, Kwang-Tup Kim. (2009) Effects of Cactus Extracts on Human Intestinal Microflora. Journal of Agriculture & Life Science Vol. 43, No. 3, pp. 45-54

4. Eun-Ji Jeong, Woon-Jong Lee, and kwang-Yup Kim. (2009) Effects of Schizandra chinensis Extract on the Growth of Intestinal Bacteria Related with Obesity. KOREAN J. FOOD SCI. TECHNOL. Vol. 41. No. 6, pp. 673-680 4. Eun-Ji Jeong, Woon-Jong Lee, and Kwang-Yup Kim. (2009) Effects of Schizandra chinensis Extract on the Growth of Intestinal Bacteria Related with Obesity. ENGLISH J. FOOD SCI. TECHNOL. Vol. 41. No. 6, pp. 673-680

5. Hye-Mi Jeong, Yi-Seul Kim, Seung-Joon Ahn, Mi-Sun Auh, Jun-Bae Ahn, and Kwang-Yup Kim. (2011) Effects of Zizyphus jujuba var. boeunesis Extracts on the Growth of Intestinal Microflora and Its Antioxidant Activities. J Korean Soc Food Sci Nutr. 40(4), 500-5085. Hye-Mi Jeong, Yi-Seul Kim, Seung-Joon Ahn, Mi-Sun Auh, Jun-Bae Ahn, and Kwang-Yup Kim. (2011) Effects of Zizyphus jujuba var. Boeunesis Extracts on the Growth of Intestinal Microflora and Its Antioxidant Activities. J Korean Soc Food Sci Nutr. 40 (4), 500-508

6. In-Sook Cho, Young-Hee Han, Gee-Young Lee, and Kyeong-Yeol Park. (2007) Search for Medicinal Plants on Improvable Effect of Intestinal Microflora. Korean J. Medicinal Crop Sci. 15(1) : 26-296. In-Sook Cho, Young-Hee Han, Gee-Young Lee, and Kyeong-Yeol Park. (2007) Search for Medicinal Plants on Improvable Effect of Intestinal Microflora. Korean J. Medicinal Crop Sci. 15 (1): 26-29

7. Jeong-Ho Lim, Bum-Keun Kim, Chan-Eun Park, Kee-Jai Park, Jong-Chan Kim. Jin-Woong, Jeong and Seung-Won Jeong. (2008) Antioxidative and Antimicrobial Activities of persimmon Leaf Tea and Green Tea. J East Asian Soc Dietary Life. 18(5) : 797-8047. Jeong-Ho Lim, Bum-Keun Kim, Chan-Eun Park, Kee-Jai Park, Jong-Chan Kim. Jin-Woong, Jeong and Seung-Won Jeong. (2008) Antioxidative and Antimicrobial Activities of Persimmon Leaf Tea and Green Tea. J East Asian Soc Dietary Life. 18 (5): 797-804

8. Jun-Young Woo, Nam-Soo Paek and Young-Man Kim. (2005) Studies on Antioxidative Effect and Lactic Acid Bacteria Growth of Persimmon Leaf Extracts. Korean J. Food & Nutr. Vol. 18, No. 1, 28-388. Jun-Young Woo, Nam-Soo Paek and Young-Man Kim. (2005) Studies on Antioxidative Effect and Lactic Acid Bacteria Growth of Persimmon Leaf Extracts. Korean J. Food & Nutr. Vol. 18, No. 1, 28-38

9. Ki-Hwan Yoo and Jong-Moon Jeong. (2009) Antioxidative and Antiallergic Effect of Persimmon Leaf Extracts. J Korean Soc Food Sci Nutr 38(12), 1691-16989. Ki-Hwan Yoo and Jong-Moon Jeong. (2009) Antioxidative and Antiallergic Effect of Persimmon Leaf Extracts. J Korean Soc Food Sci Nutr 38 (12), 1691-1698

10. Kyoung-Ae Lee, Moo-Sung Kim, Hong-Bum Cho. (2008) Effect of Extract of Fermented Dropwort on Intestinal Bacteria and Enzymes In Vitro. The Korean Journal of Microbiology, Vol. 44, No. 4, December p. 358-36110. Kyoung-Ae Lee, Moo-Sung Kim, Hong-Bum Cho. (2008) Effect of Extract of Fermented Dropwort on Intestinal Bacteria and Enzymes In Vitro. The Korean Journal of Microbiology, Vol. 44, No. 4, December p. 358-361

11. Kyoung-Ran Park, Woon-Jong Lee, Min-Gyu Cho, Eui-Seok Park, Jun-Young Jeong, Oh-Sung Kwon, Hyang-Sik Yoon, and Kwang-yup Kim. (2010) Effects of the Extracts from Gyrophora esculenta and Coriolus versicolor judae Mycelia on the Growth of Intestinal Bacteria. J Korean Soc Food Sci Nutr 39(6), 820-82511. Kyoung-Ran Park, Woon-Jong Lee, Min-Gyu Cho, Eui-Seok Park, Jun-Young Jeong, Oh-Sung Kwon, Hyang-Sik Yoon, and Kwang-yup Kim. (2010) Effects of the Extracts from Gyrophora esculenta and Coriolus versicolor judae Mycelia on the Growth of Intestinal Bacteria. J Korean Soc Food Sci Nutr 39 (6), 820-825

12. Kyung-Mi Jung, Ga-Hwa Kang, Min-Kyung Kwon, In-Kyu Song, Du-Hyun Cho and Yoen-Dae Chou. (2004) Chemical Components and Antioxidant Activity of Persimmon(Diospyros Kaki Thunb) Leaves. Korean Journal of Food Preservation Vol. 11. No. 2, pp.175-18112. Kyung-Mi Jung, Ga-Hwa Kang, Min-Kyung Kwon, In-Kyu Song, Du-Hyun Cho and Yoen-Dae Chou. (2004) Chemical Components and Antioxidant Activity of Persimmon (Diospyros Kaki Thunb) Leaves. Korean Journal of Food Preservation Vol. 11. No. 2, pp. 175-181

13. Oh Mi Hyun and kim Kwang Yup. (2010) Effects of Artemisia capillaris Extracts on Intestinal Microflora In vitro and In vivo. J Korean Soc Food Sci Nutr 39(11), 1587-159413. Oh Mi Hyun and Kim Kwang Yup. (2010) Effects of Artemisia capillaris Extracts on Intestinal Microflora In vitro and In vivo. J Korean Soc Food Sci Nutr 39 (11), 1587-1594

14. Moon SH, Park KY (2000) Antioxidative effect of persimmon leaves. Korean J Food Nutr 13 : 53-5814. Moon SH, Park KY (2000) Antioxidative effect of persimmon leaves. Korean J Food Nutr 13: 53-58

15. Park YJ, Kang MH, Kim JI, Park OJ (1995) Changes of vi-tamin C and superoxide dismutase (SOD)-like activity of persimmon leaf tea by processing method and extraction condition. Korean J Food Sci Technol 27 : 281-28515. Chang, YM, Kang MH, Kim JI, Park OJ (1995) Changes of vi-tamin C and superoxide dismutase (SOD) -like activity of persimmon leaf tea by processing method and extraction condition. Korean J Food Sci Technol 27: 281-285

16. Seung-Il Jeong, Jung-Keun Cho, Ji Ye Mok, Sang-Jun Kim, Ji-Min Park, In-Hwa Jeon, Hyeon-Soo Kim and Seon Il Jang, (2010) Antioxidant activity of Persimmon Leaves during Growth. Kor. J. Pharmacogn. 41(4) : 255-26316. Antioxidant activity of Persimmon Leaves during Growth (Jung-Il Jeong, Jung-Keun Cho, Ji Ye Mok, Sang-Jun Kim, Ji-Min Park, In-Hwa Jeon, Hyeon-Soo Kim and Seon Il Jang . Kor. J. Pharmacogn. 41 (4): 255-263

17. Woo JY, Paek NS, Kim YM (2005) Studies on antioxidative effect and lactic acid bacteria growth of persimmon leaf extracts. Korean J Food Nutr 18 : 28-3817. Woo JY, Paek NS, Kim YM (2005) Studies on antioxidative effect and lactic acid bacteria growth of persimmon leaf extracts. Korean J Food Nutr 18: 28-38

18. Woo-Young Jung and Jong-Moon Jeong. (2012) Change of Antioxidative Activity at Different Harvest Time and Improvement of Atopic Dermatitis Effects for Persimmon Leaf Extract. Kor. J. Herbology. 27(1) : 41-4918. Woo-Young Jung and Jong-Moon Jeong. (2012) Change of Antioxidative Activity at Different Harvest Time and Improvement of Atopic Dermatitis Effects for Persimmon Leaf Extract. Kor. J. Herbology. 27 (1): 41-49

19. Young-Gun Moon, Chang-Young Song, In-Kyu Yeo, Gi-Young Kim and Moon-Soo Heo. (2008) Antibacterial Activities of Suaeda maritima Extract. Journal of Life Science. Vol. 18, No. 6, 776-78119. Young-Gun Moon, Chang-Young Song, In-Kyu Yeo, Gi-Young Kim and Moon-Soo Heo. (2008) Antibacterial Activities of Suaeda maritima Extract. Journal of Life Science. Vol. 18, No. 6, 776-781

20. AOAC. : Offical methods of analysis. 15th ed. Association of official analytical chemists. Washington DC. Cd 8-35 (1990).20. AOAC. : Offical methods of analysis. 15th ed. Association of official analytical chemists. Washington DC. Cd 8-35 (1990).

21. Blios MS et al., Nature, Antioxidant determination by the use of stable free radicals. 181:1199??1200(1958).21. Blios MS et al., Nature, Antioxidant determination by the use of stable free radicals. 181: 1199-1200 (1958).

22. Moreno MIN, Isla MI, Sampietro AR, Vattuone MA (2000) Comparison of the free radical scavenging activity of propolis from several regions of Argentina. J Ethnopharmacol, 71, 109-11422. Moreno MIN, Isla MI, Sampietro AR, Vattuone MA (2000) Comparison of the free radical scavenging activity of propolis from several regions of Argentina. J Ethnopharmacol, 71, 109-114

Claims (15)

감잎 추출물을 포함하는 장내 유익균의 증식 촉진 및 장내 유해균의 생육 억제용 프리바이오틱스.
Prebiotics for promoting the proliferation of beneficial bacteria in the intestines including persimmon leaf extract and for inhibiting the growth of harmful bacteria in the intestines.
제 1 항에 있어서, 상기 장내 유익균은 비피도박테리움 속, 락토바실러스 속 또는 스트렙토코커스 속 균주인 것을 특징으로 하는 프리바이오틱스.
The prebiotics according to claim 1, wherein the intestinal beneficial bacteria are Bifidobacterium, Lactobacillus or Streptococcus.
제 2 항에 있어서, 상기 비피도박테리움 속 균주는 비피도박테리움 아돌레센티스이고, 상기 락토바실러스 속 균주는 락토바실러스 루테리이며, 상기 스트렙토코커스 속 균주는 스트렙토코커스 써모필러스인 것을 특징으로 하는 프리바이오틱스.
[Claim 3] The method according to claim 2, wherein the Bifidobacterium sp. Strain is Bifidobacterium adolescentis, the Lactobacillus sp. Strain is Lactobacillus lutea, and the Streptococcus sp. Strain is Streptococcus thermophilus Prebiotics.
제 1 항에 있어서, 상기 장내 유해균은 클로스트리디움 속, 유박테리움 속 또는 박테로이드 속 균주인 것을 특징으로 하는 프리바이오틱스.
The prebiotics according to claim 1, wherein the intestinal harmful bacteria are Clostridium genus, Yubucketium genus or Bacteroid genus.
제 4 항에 있어서, 상기 클로스트리디움 속 균주는 클로스트리디움 디피실리 또는 클로스트리디움 퍼프린젠스이고, 상기 유박테리움 속 균주는 유박테리움 리모숨이며, 상기 박테로이드 속 균주는 박테로이드 후라길리스인 것을 특징으로 하는 프리바이오틱스.
[Claim 5] The method according to claim 4, wherein the clostridial strain is Clostridium difficile or Clostridium perfringens, and the strain of the genus Yubucketium is Yubactherium limbic, Wherein the prebiotics are glycyrrhizin.
제 1 항에 있어서, 상기 감잎 추출물은 물 추출물과 에탄올 추출물의 혼합물인 것을 특징으로 하는 프리바이오틱스.
The prebiotics according to claim 1, wherein the persimmon leaf extract is a mixture of water extract and ethanol extract.
제 6 항에 있어서, 상기 물 추출물은 장내 유익균의 증식을 촉진하는 것을 특징으로 하는 프리바이오틱스.
The prebiotics according to claim 6, wherein the water extract promotes the proliferation of beneficial bacteria in the intestines.
삭제delete 제 6 항에 있어서, 상기 물 추출물은 폴리페놀을 3-15 mg/g 함유하는 것을 특징으로 하는 프리바이오틱스.
7. The prebiotics according to claim 6, wherein the water extract contains 3-15 mg / g of polyphenol.
제 6 항에 있어서, 상기 물 추출물은 플라보노이드를 30-60 μg/g 함유하는 것을 특징으로 하는 프리바이오틱스.
The prebiotics according to claim 6, wherein the water extract contains 30-60 μg / g of flavonoid.
제 6 항에 있어서, 상기 에탄올 추출물은 장내 유해균의 생육을 억제하는 것을 특징으로 하는 프리바이오틱스.
[Claim 7] The prebiotics according to claim 6, wherein the ethanol extract inhibits the growth of harmful bacteria in the intestines.
제 6 항에 있어서, 상기 에탄올 추출물은 1-25 mg/mL에서 최소 저해농도를 갖는 것을 특징으로 하는 프리바이오틱스.
7. The prebiotics of claim 6, wherein the ethanol extract has a minimal inhibitory concentration at 1-25 mg / mL.
삭제delete 제 6 항에 있어서, 상기 에탄올 추출물은 폴리페놀을 3-15 mg/g 함유하는 것을 특징으로 하는 프리바이오틱스.
7. The prebiotics according to claim 6, wherein the ethanol extract contains 3-15 mg / g of polyphenol.
제 6 항에 있어서, 상기 에탄올 추출물은 플라보노이드를 10-40 μg/g 함유하는 것을 특징으로 하는 프리바이오틱스.7. The prebiotics according to claim 6, wherein the ethanol extract contains 10-40 μg / g of flavonoid.
KR1020120128761A 2012-11-14 2012-11-14 Prebiotics Containing Extractions of Persimmon Leaves for Useful Strains in intestine KR101395875B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020120128761A KR101395875B1 (en) 2012-11-14 2012-11-14 Prebiotics Containing Extractions of Persimmon Leaves for Useful Strains in intestine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020120128761A KR101395875B1 (en) 2012-11-14 2012-11-14 Prebiotics Containing Extractions of Persimmon Leaves for Useful Strains in intestine

Publications (1)

Publication Number Publication Date
KR101395875B1 true KR101395875B1 (en) 2014-06-19

Family

ID=51131178

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020120128761A KR101395875B1 (en) 2012-11-14 2012-11-14 Prebiotics Containing Extractions of Persimmon Leaves for Useful Strains in intestine

Country Status (1)

Country Link
KR (1) KR101395875B1 (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20170017176A (en) 2015-08-05 2017-02-15 (주)아모레퍼시픽 Composition for increasing lactic acid bacteria in intestine and method for producing lactic acid bacteria using the same
US9682113B2 (en) 2015-04-21 2017-06-20 Korea Institute Of Science And Technology Method for preventing, improving or treating cornea damages using extracts of Diospyros kaki
KR20180104518A (en) * 2017-03-13 2018-09-21 한양대학교 산학협력단 Prebiotics Containing Grape seed flour
KR20190081719A (en) 2017-12-29 2019-07-09 산청기능성콩 영농조합법인 Probiotics with anti-inflammatory activation that contains charge complex extract and its method of manufacture
KR102048434B1 (en) * 2018-12-18 2019-11-25 한국식품연구원 A composition as a prebiotic for improving intestinal microflora containing High-molecular fraction from radish leave
WO2020130296A1 (en) * 2018-12-18 2020-06-25 한국식품연구원 Composition for improving gut flora, or composition for alleviating, preventing or treating gut inflammation, leaky gut syndrome, obesity, or metabolic intestinal disorders, comprising extract of radish greens
KR20220159594A (en) 2021-05-26 2022-12-05 동의대학교 산학협력단 Prebiotics composition containing oligosaccharide isolated from soybean fermented food as active ingredient and method for manufacturing same
ES2944596A1 (en) * 2021-12-21 2023-06-22 Univ Miguel Hernandez De Elche Persimmon DIETARY FIBER FOR USE WITH BENEFICIAL MICRO-ORGANISMS (Machine-translation by Google Translate, not legally binding)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100628417B1 (en) 2004-10-28 2006-09-26 (주)포테이토밸리 Extract having growth-inhibiting and promoting effects of human intestinal bacteria extracted from valley potato cultivars and functional food using the same

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100628417B1 (en) 2004-10-28 2006-09-26 (주)포테이토밸리 Extract having growth-inhibiting and promoting effects of human intestinal bacteria extracted from valley potato cultivars and functional food using the same

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
한국식품영양과학회지, Vol.40, pp.500-508(2011.) *
한국식품영양학회지, Vol.18, pp.28-38(2005.) *
한국영양학회지, Vol.36, pp.133-146(2003.) *

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9682113B2 (en) 2015-04-21 2017-06-20 Korea Institute Of Science And Technology Method for preventing, improving or treating cornea damages using extracts of Diospyros kaki
KR20170017176A (en) 2015-08-05 2017-02-15 (주)아모레퍼시픽 Composition for increasing lactic acid bacteria in intestine and method for producing lactic acid bacteria using the same
KR20180104518A (en) * 2017-03-13 2018-09-21 한양대학교 산학협력단 Prebiotics Containing Grape seed flour
KR101973514B1 (en) 2017-03-13 2019-04-29 한양대학교 산학협력단 Prebiotics Containing Grape seed flour
KR20190081719A (en) 2017-12-29 2019-07-09 산청기능성콩 영농조합법인 Probiotics with anti-inflammatory activation that contains charge complex extract and its method of manufacture
KR102048434B1 (en) * 2018-12-18 2019-11-25 한국식품연구원 A composition as a prebiotic for improving intestinal microflora containing High-molecular fraction from radish leave
WO2020130296A1 (en) * 2018-12-18 2020-06-25 한국식품연구원 Composition for improving gut flora, or composition for alleviating, preventing or treating gut inflammation, leaky gut syndrome, obesity, or metabolic intestinal disorders, comprising extract of radish greens
KR20220159594A (en) 2021-05-26 2022-12-05 동의대학교 산학협력단 Prebiotics composition containing oligosaccharide isolated from soybean fermented food as active ingredient and method for manufacturing same
ES2944596A1 (en) * 2021-12-21 2023-06-22 Univ Miguel Hernandez De Elche Persimmon DIETARY FIBER FOR USE WITH BENEFICIAL MICRO-ORGANISMS (Machine-translation by Google Translate, not legally binding)

Similar Documents

Publication Publication Date Title
KR101395875B1 (en) Prebiotics Containing Extractions of Persimmon Leaves for Useful Strains in intestine
Gosset-Erard et al. Identification of punicalagin as the bioactive compound behind the antimicrobial activity of pomegranate (Punica granatum L.) peels
Filannino et al. Lactic acid fermentation of cactus cladodes (Opuntia ficus-indica L.) generates flavonoid derivatives with antioxidant and anti-inflammatory properties
Jaziri et al. Effect of green and black teas (Camellia sinensis L.) on the characteristic microflora of yogurt during fermentation and refrigerated storage
Wen et al. Effects of probiotic litchi juice on immunomodulatory function and gut microbiota in mice
RU2463067C2 (en) Method for modification of polyphenol-containing herbal materials and use of modified polyphenol-containing herbal materials in medicine
Li et al. Extraction and characterization of phenolic compounds with antioxidant and antimicrobial activities from pickled radish
KR20120022795A (en) Agent for regulating composition ratio of intestinal bacterial flora
Wang et al. Evaluating the changes in phytochemical composition, hypoglycemic effect, and influence on mice intestinal microbiota of fermented apple juice
Mianabadi et al. Antimicrobial and Anti-oxidative Effects of Methanolic Extract of Dorema aucheri Boiss.
Jiang et al. A review on the gastrointestinal protective effects of tropical fruit polyphenols
Değirmencioğlu et al. Health benefits of kombucha tea enriched with olive leaf and honey
Ondarza Cactus mucilages: nutritional, health benefits and clinical trials
Zailani et al. Substrates and metabolic pathways in symbiotic culture of bacteria and yeast (scoby) fermentation: A mini review
JP4119656B2 (en) Antioxidant
Saelee et al. The influence of pasteurization and starter culture on methanol content and bio-profile of fermented Morinda citrifolia Linn.(Noni) fruit juice
Jeong et al. Antimicrobial activity of catechol isolated from Diospyros kaki Thunb. roots and its derivatives toward intestinal bacteria
Ibrahim et al. Evaluation of the antioxidant and antimicrobial activities of fucoxanthin from Dilophys fasciola and as a food additive in stirred yoghurt
KR101918942B1 (en) Fermented drink using glycine max (L.) merrill and herbal ingredients and manufacturing method thereof
KR102464052B1 (en) Composition of complex-fermented sprout ginseng having increased ginsenoside F2, Rg3, Rd2 and compound K, chlorogenic acid, coumaric acid, catechin and quercetin, and preparation method thereof
KR100876667B1 (en) The complex extract of Myristica fra grans Houtt, Cinnamomum cassia Blume and Alpinia officinarum Hance, antibacterial activity fraction isolated, preparation method and uses thereof
Kwon et al. In-vitro prebiotic activity of grape seed flour highly rich in flavonoid and dietary fiber
KR20200072011A (en) Method for producing fermented Arctium lappa using Lactobacillus brevis SRCM101607
Liu et al. Changes in polyphenols and antioxidant properties of pomegranate peels fermented by urolithin A-producing Streptococcus thermophilus FUA329
ES2370839B1 (en) USE OF LACTIC BACTERIA TO PRESERVE THE FLAVANOLS OF A FOOD PRODUCT AND PREVENT WINE WRAPPING.

Legal Events

Date Code Title Description
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20170502

Year of fee payment: 4

FPAY Annual fee payment

Payment date: 20180509

Year of fee payment: 5

FPAY Annual fee payment

Payment date: 20190502

Year of fee payment: 6